Recommended

New webinar: Overcoming critical challenges in AI-driven drug discovery
Watch on demand: Rapid cell-based profiling of multi-target anti-obesity drugs Watch here!
Download now: Unlock the power of stem cell therapy and discover the potential for new therapies for primary open-angle glaucoma
Brand new Beyond the Lab report on antibodies… Download NOW!
article

Drug Target Review Antibodies ebook 2021

Posted: 22 September 2021 | | No comments yet

This ebook has features on the development of intranasally-delivered antibodies to combat SARS-CoV-2 and how the structure of a nanobody was determined using nuclear magnetic resonance methods.

In this collection of articles, Dr Steve Carroll explains why antibody therapeutics continue to be required in the fight against COVID-19. He also outlines recent research into an Immunoglobulin M (IgM) antibody platform that could combat SARS‑CoV-2 and its variants.

In a Q&A, Professor Gennaro Esposito discusses nanobodies and why this class of small protein, derived from antibodies occurring in camelids and sharks, has the potential to fight a wide range of diseases.

Included in this ebook:

  • An IgM antibody platform to tackle SARS‑CoV-2 and its variants
    Dr Steve Carroll, IGM Biosciences
  • Determining the structure of nanobodies using nuclear magnetic resonance spectroscopy
    Professor Gennaro Esposito, New York University (NYU) Abu Dhabi

    To read this ebook in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of NanoTemper Technologies and Sartorius

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Leave a Reply

    Your email address will not be published. Required fields are marked *